The Company intends to monitor the bid price of its ADSs and to consider available options if its ADSs do not trade at a level likely to result in the Company regaining compliance with Nasdaq's ...

CD163 is a macrophage receptor that clears hemoglobin-haptoglobin complexes from blood, preventing oxidative damage and also ...

G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...

Charles Schwab Investment Management Inc. acquired a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB – Free Report) during the 4th quarter, according to the company in its most recent Form ...

Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.